Cross Amanda J, Buchbinder Rachelle, Bourne Allison, Maher Christopher, Mathieson Stephanie, Lin Chung-Wei C, O'Connor Denise A
Monash Department of Clinical Epidemiology, Cabrini Institute, Malvern, Victoria, Australia
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University Faculty of Medicine Nursing and Health Sciences, Melbourne, Victoria, Australia.
BMJ Open. 2019 Nov 12;9(11):e034039. doi: 10.1136/bmjopen-2019-034039.
The over-prescription and overuse of opioid analgesics for chronic non-cancer pain (CNCP) is a growing issue. Synthesis of evidence about the barriers and enablers to reducing long-term opioid prescribing and use will enable the development of tailored interventions to address both problems.
To synthesise the barriers and enablers to monitoring the ongoing appropriateness of opioid treatment and deprescribing opioids for CNCP from the clinician, patient and general public point of view, and to map the findings to the Theoretical Domains Framework (TDF).
We will perform a qualitative evidence synthesis using the TDF. We will include qualitative research that has explored clinician, patient and the general public's perceptions regarding barriers and enablers to monitoring and deprescribing opioids for CNCP. Studies will be identified via searches in MEDLINE, EMBASE, CINAHL, AMED and PsycINFO. Databases will be searched from inception to July 2019, and the studies must be published in English. Article selection and data extraction will be completed independently by two review authors. Methodological quality of included studies will be independently assessed by two review authors using the Critical Appraisal Skills Programme quality assessment tool. We will conduct thematic synthesis and then map identified themes and sub-themes to TDF domains. Confidence in synthesis findings will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation Confidence in the Evidence from Reviews of Qualitative Research tool.
Ethical approval is not required to conduct this review. We will publish the results in a peer-reviewed journal.
CRD42019140784.
阿片类镇痛药在慢性非癌性疼痛(CNCP)治疗中的过度处方和过度使用是一个日益严重的问题。综合有关减少长期阿片类药物处方和使用的障碍及促进因素的证据,将有助于制定针对性的干预措施来解决这两个问题。
从临床医生、患者和公众的角度,综合分析监测阿片类药物治疗持续适宜性及减少CNCP阿片类药物处方的障碍和促进因素,并将研究结果映射到理论领域框架(TDF)。
我们将使用TDF进行定性证据综合分析。我们将纳入探索临床医生、患者和公众对监测及减少CNCP阿片类药物处方的障碍和促进因素看法的定性研究。研究将通过检索MEDLINE、EMBASE、CINAHL、AMED和PsycINFO来确定。数据库将从创建至2019年7月进行检索,且研究必须以英文发表。文章筛选和数据提取将由两位综述作者独立完成。纳入研究的方法学质量将由两位综述作者使用批判性评价技能计划质量评估工具独立评估。我们将进行主题综合分析,然后将确定的主题和子主题映射到TDF领域。将使用定性研究综述证据的推荐分级评估、发展和评价信心工具来评估综合研究结果的可信度。
进行本综述无需伦理批准。我们将在同行评审期刊上发表研究结果。
PROSPERO注册号:CRD42019140784。